Sanofi-aventis to build a vaccine facility in China
- Details
- Category: Sanofi
Sanofi-aventis announced the signature in Beijing of an agreement between the Chinese authorities and sanofi-aventis to build a facility to manufacture influenza vaccine, during an official ceremony attended by Hu Jintao, President of the People's Republic of China, and Nicolas Sarkozy, President of the French Republic, in China for a State Visit.
Collexis Holdings, Inc. Acquires SyynX Solutions GmbH, Expands Application Portfolio
- Details
- Category: Business
Collexis Holdings, Inc. (OTCBB: CLXS) has acquired its long-time development partner, SyynX Solutions, a privately-held software company based in Cologne, Germany. SyynX Solutions will remain as a subsidiary of Collexis Holdings â with the amendment "a Collexis company", and will take care of existing customers and drive Collexis' business in Europe.
CIBA Vision announces settlement of patent litigation with CooperVision, Inc.
- Details
- Category: Business
CIBA Vision, the eye care unit of Novartis, has reached a final global patent litigation settlement agreement with CooperVision, Inc. (NYSE: COO) that resolves all current patent infringement lawsuits between the two companies. CIBA Vision has licensed its so called "Nicolson" patents to CooperVision. This will enable both companies to move forward in bringing forth new and improved innovations to meet the needs of eye care professionals and consumers.
GlaxoSmithKline to acquire Reliant Pharmaceuticals
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline and Reliant Pharmaceuticals Inc. announced that they had reached an agreement under which Reliant will be acquired by GSK for $1.65 billion (£800 million) in cash. Reliant, a privately held specialty pharmaceutical company focused on cardiovascular therapies, recorded net sales of $341 million in the nine months ending 30 September 2007, an increase of 62% over the comparable time period a year earlier.
Novartis withdraws its application to extend the marketing authorisation for Zometa
- Details
- Category: Novartis
The European Medicines Agency (EMEA) has been formally notified by Novartis Pharma AG of its decision to withdraw the application to extend the marketing authorisation to include a new indication for the medicinal product Zometa (zoledronic acid).
Nycomed significantly increases profitability
- Details
- Category: Nycomed
In the first nine months of 2007 Nycomed increased adjusted EBITDA by 29.4% to € 940.8 million compared to the same period of last year. The performance improvement is a result of strong pantoprazole sales in the US and repatriation of pantoprazole in certain markets while at the same time, spending levels were reduced.
Celgene to Acquire Pharmion for $2.9 Billion in Cash and Stock
- Details
- Category: Financial
Celgene Corporation (Nasdaq: CELG) and Pharmion Corporation (Nasdaq: PHRM) jointly announced the signing of a definitive merger agreement pursuant to which Celgene has agreed to acquire Pharmion. Under the terms of the merger agreement, Celgene will acquire all of the outstanding shares of Pharmion common stock for $72.00 per share payable in a combination of cash and shares of Celgene common stock. The transaction is expected to be slightly dilutive to earnings in 2008 and accretive in 2009 and beyond.
More Pharma News ...
- Menveo(TM) (MenACWY-CRM) vaccine to demonstrate an excellent immune response in infants
- Pfizer to Acquire Coley Pharmaceutical Group
- Abbott Partners With Operation Smile to Support 40 Medical Missions in 25 Countries
- Award recognises and rewards journalism that extends public awareness and understanding of COPD
- Roche signs licensing and settlement agreements for Hepatitis C immunodiagnostics
- Novo Nordisk celebrates first ever UN-observed World Diabetes Day
- Novel agent for treatment of Parkinson's disease in clinical development